LivDerm

 

LivDerm
Avatar

The Future of Atopic Dermatitis, JAK Inhibitors, and Monoclonal Antibodies: What Are the Differences, Efficacy, and Safety With New Pharmacologics?

By LivDerm FEATURING Lawrence Schachner
By LivDerm FEATURING Lawrence Schachner
416 views
February 19, 2021
Comments 0
Login to view comments. Click here to Login
2021 Masters of Pediatric Dermatology
08:08

Welcome Message & Highlights of the South Beach Symposium and Master…

LivDerm

L. Schachner

6 views
06:30

Telehealth vs. Patient Visits Study Highlights: Elevating the Patien…

LivDerm

M. Kaufmann

228 views
05:01

The Future of Atopic Dermatitis, JAK Inhibitors, and Monoclonal Anti…

LivDerm

L. Schachner

416 views
04:56

COVID-19 & Late Cutaneous Findings in Pediatrics: What Are “COVID To…

LivDerm

A. Maderal

56 views
13:10

New Topical Agents for Preteen Acne: What Is the Safety/Efficacy of …

LivDerm

J. E. Keri

537 views
03:04

New Oral Agents for Preteen Acne: Sarecycline Uses, Dosage, and Side…

LivDerm

J. E. Keri

346 views
03:23

Management of Atopic Dermatitis in Infancy/Childhood: A 3 Day Rate o…

LivDerm

L. Schachner

789 views
02:40

Atopic Dermatitis Treatment: The Simple Sliding Scale for Mild to Mo…

LivDerm

L. Schachner

1.5K views
05:06

Innovation in Acne Treatment: What Are the Latest FDA Approved Drugs…

LivDerm

L. Schachner

379 views
09:35

Atopic Dermatitis & Impetigo Management: How to Effectively Use Scha…

LivDerm

L. Schachner

575 views
05:03

Dermatological Manifestations of COVID-19 in Children: What Are the …

LivDerm

A. Maderal

457 views